Frank Holzer, General Manager and major shareholder of URSAPHARM Germany
With currently around 450 employees and a turn over of more than 85 million € in the group URSAPHARM is one of the leaders on the German market of ophthalmology and, with reference to the indication of the dry eye syndrome, even in Europe and many countries in the world.